REDUCED FREQUENCY TRASTUZUMAB DOSING REGIMENS.

被引：0
|
作者：
Hsieh, P. [1 ]
Kacew, A. [1 ]
Strohbehn, G. [1 ]
Nanda, R. [1 ]
Ratain, M. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIV-015
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [21] Allografting with fludarabine-based immunosuppressive conditioning regimens.
    Corsetti, MT
    Beltrami, G
    Cavaliere, M
    Scalzulli, P
    Carella, AM
    Greco, M
    Carella, AM
    BLOOD, 2001, 98 (11) : 414A - 415A
  • [22] Islet Xenotransplantation: A Quest for Clinically Available Immunosuppression Regimens.
    Gao, Q.
    Davis, R.
    Mulvihill, M.
    Song, M.
    Leopardi, F.
    Ribeiro, M.
    How, T.
    Devi, G.
    Collins, B.
    Kirk, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 280 - 280
  • [23] Impact of chimerism and other transplant variables on allogeneic transplant outcome after reduced intensity conditioning (RIC) regimens.
    Corbella, Veronica Ortiz
    Le, Quoc-Hung
    Nicolini, Franck E.
    Thiebaut, Anne
    Thomas, Xavier
    Chelgoum, Youcef
    Ducastelle, Sophie
    Mollet, Isabelle
    Dubois, Valerie
    Michallet, Mauricette
    BLOOD, 2006, 108 (11) : 406B - 406B
  • [24] Optimization of dosing regimens and dosing in special populations
    Sime, F. B.
    Roberts, M. S.
    Roberts, J. A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (10) : 886 - 893
  • [25] Acute side effects of ATG with different infusion regimens.
    Ermakov, B
    Peters, C
    Alexeitschik, A
    Matthes-Martin, S
    Ladenstein, R
    Mann, G
    Holter, W
    Gadner, H
    BONE MARROW TRANSPLANTATION, 1998, 21 : S48 - S48
  • [26] Low frequency of systemic reactions in cluster up dosing regimens in subcutaneous immunotherapy
    Peralta Filpo, G.
    Escobar Bolanos, C.
    Cimarra, M.
    Rodriguez Alvarez, M.
    Gonzalez Gutierrez, M. L.
    Robledo Echarren, T.
    Fernandez-Rivas, M.
    ALLERGY, 2013, 68 : 473 - 474
  • [27] Combination of antiangiogenic agents with standard cytotoxic therapies in therapeutic regimens.
    Teicher, BA
    CLINICAL CANCER RESEARCH, 1999, 5 : 3878S - 3879S
  • [28] Allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Another step towards curing by immunologic methods
    Conde, E
    MEDICINA CLINICA, 2001, 116 (15): : 577 - 579
  • [29] Dentine caries incidence following use of topical fluoride regimens.
    Woodley, NJ
    Griffiths, BM
    Pearson, GJ
    Newman, HN
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 432 - 432
  • [30] DOSING REGIMENS IN THE TREATMENT OF TUBERCULOSIS
    BLOMBULOW, B
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, : 258 - 261
12345